Aldo T Iacono

Summary

Affiliation: University of Maryland
Country: USA

Publications

  1. ncbi Evaluation of the electronic version of the questionnaire for lung transplant patients
    Annette De Vito Dabbs
    University of Pittsburgh, PA, USA
    Prog Transplant 17:29-35. 2007
  2. ncbi Lung transplantation following 107 days of extracorporeal membrane oxygenation
    Aldo Iacono
    Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, 110 South Paca Street, 2nd Floor, Baltimore, MD 21201, USA
    Eur J Cardiothorac Surg 37:969-71. 2010
  3. ncbi A randomized trial of inhaled cyclosporine in lung-transplant recipients
    Aldo T Iacono
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA
    N Engl J Med 354:141-50. 2006
  4. ncbi HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction
    Alin L Girnita
    Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA
    Am J Transplant 5:131-8. 2005
  5. ncbi HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection
    Alin L Girnita
    Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261, USA
    J Heart Lung Transplant 23:1135-41. 2004
  6. ncbi Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation?
    Annette De Vito Dabbs
    Department of Acute and Tertiary Care, School of Nursing, University of Pittsburgh, 336 Victoria Bldg, Pittsburgh, PA 15261, USA
    Heart Lung 33:372-80. 2004
  7. ncbi Pattern and predictors of early rejection after lung transplantation
    Annette DeVito Dabbs
    Department of Acute and Tertiary Care, School of Nursing, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Am J Crit Care 12:497-507. 2003
  8. ncbi Statin use is associated with improved function and survival of lung allografts
    Bruce A Johnson
    Department of Medicine, University of Pittsburgh, 628 NW MUH, 3459 Fifth Ave, Pittsburgh, PA 15213, USA
    Am J Respir Crit Care Med 167:1271-8. 2003
  9. ncbi Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients
    Gilbert J Burkart
    Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Pharm Res 20:252-6. 2003
  10. ncbi Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls
    Jose P Garcia
    Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Thorac Cardiovasc Surg 142:755-61. 2011

Collaborators

Detail Information

Publications17

  1. ncbi Evaluation of the electronic version of the questionnaire for lung transplant patients
    Annette De Vito Dabbs
    University of Pittsburgh, PA, USA
    Prog Transplant 17:29-35. 2007
    ..It is feasible to complete in the clinical setting and recipients are highly satisfied with its use. Its computerized functionality enhances assessment and management of symptoms over time...
  2. ncbi Lung transplantation following 107 days of extracorporeal membrane oxygenation
    Aldo Iacono
    Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, 110 South Paca Street, 2nd Floor, Baltimore, MD 21201, USA
    Eur J Cardiothorac Surg 37:969-71. 2010
    ..As ECMO use becomes more frequent, it becomes critical to determine criteria that would optimise patient selection for transplantation from ECMO...
  3. ncbi A randomized trial of inhaled cyclosporine in lung-transplant recipients
    Aldo T Iacono
    Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA
    N Engl J Med 354:141-50. 2006
    ..Topical delivery of cyclosporine in addition to conventional systemic immunosuppression might help prevent acute and chronic rejection events...
  4. ncbi HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction
    Alin L Girnita
    Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA
    Am J Transplant 5:131-8. 2005
    ....
  5. ncbi HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection
    Alin L Girnita
    Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15261, USA
    J Heart Lung Transplant 23:1135-41. 2004
    ..These lung-transplanted patients may benefit from an altered strategy of immunosuppression...
  6. ncbi Are symptom reports useful for differentiating between acute rejection and pulmonary infection after lung transplantation?
    Annette De Vito Dabbs
    Department of Acute and Tertiary Care, School of Nursing, University of Pittsburgh, 336 Victoria Bldg, Pittsburgh, PA 15261, USA
    Heart Lung 33:372-80. 2004
    ..CONCLUSIONS: Although symptoms may alert LTR to changes in their condition, no symptoms (respiratory, general, or activities of daily living [ADL]) differentiate between grades of rejection or pulmonary infection...
  7. ncbi Pattern and predictors of early rejection after lung transplantation
    Annette DeVito Dabbs
    Department of Acute and Tertiary Care, School of Nursing, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    Am J Crit Care 12:497-507. 2003
    ..03) and higher cumulative rejection scores (P = .004) were significantly more likely than other recipients to have serious rejection during the first year after transplantation...
  8. ncbi Statin use is associated with improved function and survival of lung allografts
    Bruce A Johnson
    Department of Medicine, University of Pittsburgh, 628 NW MUH, 3459 Fifth Ave, Pittsburgh, PA 15213, USA
    Am J Respir Crit Care Med 167:1271-8. 2003
    ..01). The 6-year survival of recipients taking statins (91%) was much greater than that of control subjects (54%) (p < 0.01). These data suggest statin use may have substantial clinical benefits after pulmonary transplantation...
  9. ncbi Lung deposition and pharmacokinetics of cyclosporine after aerosolization in lung transplant patients
    Gilbert J Burkart
    Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    Pharm Res 20:252-6. 2003
    ..The objective of this study is to evaluate the lung deposition and systemic absorption of aCsA after aerosolized cyclosporine administration in LTx patients in the immediate postoperative period...
  10. ncbi Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls
    Jose P Garcia
    Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD 21201, USA
    J Thorac Cardiovasc Surg 142:755-61. 2011
    ..This strategy has been enabled by the introduction of a dual-lumen draw and return cannula placed via the internal jugular vein...
  11. ncbi Using conceptual triangulation to develop an integrated model of the symptom experience of acute rejection after lung transplantation
    Annette De Vito Dabbs
    School of Nursing, University of Pittsburgh, Pittsburgh, PA 15261, USA
    ANS Adv Nurs Sci 27:138-49. 2004
    ..1997;20:1-12). The integrated model will guide the development of interventions to promote effective patterns of symptom recognition and reporting of acute rejection...
  12. ncbi Endobronchial metallic stent placement for airway complications after lung transplantation: longitudinal results
    Karen E A Burns
    Division of Pulmonary Transplantation, and Pulmonary, Critical Care Medicine, University of Pittsburgh Medical Center-Presbyterian Hospital, Pittsburgh, Pennsylvania, USA
    Ann Thorac Surg 74:1934-41. 2002
    ....
  13. ncbi Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia
    Nevins W Todd
    Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA
    J Heart Lung Transplant 29:188-94. 2010
    ..We sought to determine the prevalence of pulmonary hypertension in sub-groups of patients with interstitial pneumonia and to investigate possible associations between pulmonary vascular hemodynamics and pulmonary function...
  14. ncbi Evaluating the reliability and validity of the Questionnaire for Lung Transplant Patients
    Annette De Vito Dabbs
    Department of Acute/Tertiary Care, School of Nursing, University of Pittsburgh, Pittsburgh, PA, USA
    Prog Transplant 12:191-8; quiz 199-200. 2002
    ....
  15. ncbi Roles of T lymphocytes in pulmonary fibrosis
    Irina G Luzina
    University of Maryland School of Medicine and Baltimore VA Medical Center, Baltimore, MD 21201, USA
    J Leukoc Biol 83:237-44. 2008
    ..Phenotypic reshaping, rather than elimination of the infiltrating pulmonary T lymphocytes, may be a promising approach to improving outcomes in patients with pulmonary fibrosis...
  16. ncbi Obliterative bronchiolitis in the lung transplant recipient. A powerful foe
    Deidre A Smith-Seiler
    University of Pittsburgh, USA
    Adv Nurse Pract 12:69-74. 2004
  17. ncbi Pulmonary embolism on postmortem examination: an under-recognized complication in lung-transplant recipients?
    Karen E A Burns
    Division of Critical Care Medicine, London Health Sciences Center-Victoria Hospital, London, Ontario, Canada
    Transplantation 77:692-8. 2004
    ..Heart-lung recipients were at lower risk for PE compared with double- and single-lung recipients. PE may be an under-appreciated complication contributing to respiratory failure in the early postoperative period...